SCHEMBL29889382

SCHEMBL29889382

COc1ccc(-c2ccncc2)c2nc(NC(=O)N3CCC(C)(O)CC3)[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.45
▸ ADORA1 P30542 4/20 0.45
▸ ADORA3 P0DMS8 1/20 0.45
▸ ADORA2B P29275 1/20 0.45
▸ CYP3A4 P08684 5/20 0.41
▸ CYP1A2 P05177 3/20 0.41
▸ HDAC2 Q92769 2/20 0.38
▸ TSHR P16473 2/20 0.38
▸ HDAC1 Q13547 1/20 0.37
▸ CYP2C9 P11712 2/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ CYP2C19 P33261 1/20 0.36
▸ CYP46A1 Q9Y6A2 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.36
▸ TLR8 Q9NR97 1/20 0.36
▸ TLR7 Q9NYK1 1/20 0.36
▸ HIF1A Q16665 1/20 0.35
▸ PDE4A P27815 1/20 0.35
▸ PKM P14618 1/20 0.35
▸ MAPK1 P28482 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20765033 1.00 ADORA2A (0.45) ADORA2AADORA1ADORA3ADORA2BCYP3A4
SCHEMBL29889767 0.93 ADORA2A (0.45) ADORA2AADORA1ADORA3ADORA2BCYP3A4
SCHEMBL29890474 0.91 ADORA2A (0.43) ADORA2AADORA1ADORA3ADORA2BHDAC2
SCHEMBL20765052 0.91 ADORA2A (0.43) ADORA2AADORA1ADORA3ADORA2BHDAC2
SCHEMBL29889783 0.88 ADORA3 (0.43) ADORA2AADORA1ADORA3ADORA2BHDAC1
SCHEMBL20765100 0.88 ADORA3 (0.43) ADORA2AADORA1ADORA3ADORA2BHDAC1
SCHEMBL22183188 0.87 ADORA2A (0.42) ADORA2AADORA1ADORA3ADORA2BL3MBTL1
SCHEMBL29890331 0.87 ADORA2A (0.42) ADORA2AADORA1ADORA3ADORA2BL3MBTL1
SCHEMBL20765144 0.87 CYP3A4 (0.41) ADORA2AADORA1ADORA3ADORA2BCYP3A4
SCHEMBL29889686 0.87 CYP3A4 (0.41) ADORA2AADORA1ADORA3ADORA2BCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220306588-A1 BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS MERCK PATENT GMBH (DE) 2022-09-29 — — US disclosed
US-11453647-B2 Benzimidazole derivatives as adenosine receptor antagonists MERCK PATENT GMBH (DE) 2022-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220306588-A1 BEZIMIDAZOLE DERIVATIVES AS ADENOSINE RECEPTOR ANTAGONISTS ADORA1, ADORA2A, ADORA3 ADORA2A 2/4885ADORA1 1/4885ADORA3 3/4885
US-11453647-B2 Benzimidazole derivatives as adenosine receptor antagonists ADORA1, ADORA2A, ADORA3 ADORA2A 2/4885ADORA1 1/4885ADORA3 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback